A Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell Disease (GRASP, BMT CTN 2001) (GRASP)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05353647 |
|
Recruitment Status :
Recruiting
First Posted : April 29, 2022
Last Update Posted : April 23, 2024
|
Sponsor:
David Williams
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
California Institute for Regenerative Medicine (CIRM)
bluebird bio
Blood and Marrow Transplant Clinical Trials Network
Information provided by (Responsible Party):
David Williams, Boston Children's Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2026 |
| Estimated Study Completion Date : | May 2026 |